Correlation Between Anti-Myelin Proteolipid Protein (PLP) Antibodies and Disease Severity in Multiple Sclerosis Patients With PLP Response-Permissive HLA Types.

When the ELISA data from MS patients and controls shown in Figure 2A was assessed on the basis of carriage of these PLP response-permissive HLA types, there was still a highly significant difference between MS patients and controls for the PLP response-permissive HLA types, but not for those individuals who do not carry these HLA types ( Figure 4 ).

also in 132,142 other papers